Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-05-02FDA Approved: FLUOXETINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for the generic fluoxetine from Aurobindo Pharma Limited (ANDA213265).
-
FDA approval · 2024-04-19FDA Approved: CELEXA — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Celexa (citalopram) submitted by Allergan, Inc.
-
FDA approval · 2024-04-19FDA Approved: LEXAPRO — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Lexapro (escitalopram) submitted by Allergan, Inc., advancing a labeling action for the product.
-
FDA approval · 2024-04-19FDA Approved: VIIBRYD — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for VIIBRYD (vilazodone hydrochloride) from Allergan, Inc.
-
FDA approval · 2024-04-19FDA Approved: FETZIMA — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for FETZIMA (levomilnacipran hydrochloride) from Allergan, Inc. The action constitutes an additional…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-04-16FDA Approved: CITALOPRAM — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for citalopram from Cipla USA Inc., authorizing changes to the drug's labeling.
-
FDA approval · 2024-04-15FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for escitalopram oxalate from Amneal Pharmaceuticals LLC, approving a generic version of escital…
-
FDA approval · 2024-04-05FDA Approved: FLUOXETINE — Original Application (Strides Pharma Science Limited)
FDA approved an Original Application for a generic Fluoxetine from Strides Pharma Science Limited, enabling a generic version of fluoxetine …
-
FDA approval · 2024-04-03FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion hydrochloride sustained-release (Actavis) under an ANDA, approving the supplemental fi…
-
FDA approval · 2024-03-28FDA Approved: CITALOPRAM — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved a supplemental application for citalopram by Torrent Pharmaceuticals Limited, indicating an approved change related to the …
-
FDA approval · 2024-03-21FDA Approved: ESCITALOPRAM ORAL SOLUTION — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for escitalopram oral solution from Chartwell RX, LLC, recognizing a generic formulation.
-
FDA approval · 2024-03-19FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for venlafaxine hydrochloride from Camber Pharmaceuticals, approving a new supplement to an existing…
-
FDA approval · 2024-03-15FDA Approved: ARIPIPRAZOLE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for aripiprazole submitted by Chartwell RX, LLC, indicating regulatory approval of a supplement rela…
-
FDA approval · 2024-03-11FDA Approved: QUETIAPINE — Supplemental Application (Solco Healthcare U.S., LLC)
FDA approved a supplemental application for a generic version of quetiapine, enabling Solco Healthcare U.S., LLC to market a generic quetiap…
-
FDA approval · 2024-03-08FDA Approved: ESCITALOPRAM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for escitalopram oxalate (escitalopram) by Sun Pharmaceutical Industries, enabling marketing of the …
-
FDA approval · 2024-02-29FDA Tentative Approval: TRAZODONE HYDROCHLORIDE — Supplemental Application (Zydus Lifesciences Limited)
FDA issued tentative approval for a generic trazodone hydrochloride product from Zydus Lifesciences Limited under ANDA205253. This is a tent…
-
FDA approval · 2024-02-05FDA Approved: ESCITALOPRAM — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for escitalopram from Macleods Pharmaceuticals Limited, authorizing changes to the product labeling.
-
FDA approval · 2024-02-05FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Exelan Pharmaceuticals Inc.)
FDA approved a supplemental application for Escitalopram Oxalate (escitalopram) by Exelan Pharmaceuticals Inc. under ANDA078604.
-
FDA approval · 2024-02-02FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for sertraline hydrochloride from Rising Pharma Holdings, Inc., resulting in approval of a gener…
-
FDA approval · 2024-02-01FDA Approved: BUPROPION HYDROCHLORIDE (XL) — Supplemental Application (Exelan Pharmaceuticals Inc.)
FDA approved a supplemental application for Bupropion Hydrochloride (XL) from Exelan Pharmaceuticals, authorizing continued marketing of the…
-
FDA approval · 2024-01-30FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Epic Pharma, LLC)
The FDA approved a supplemental application for venlafaxine hydrochloride from Epic Pharma, LLC, supporting the approval of a generic produc…
-
FDA approval · 2024-01-19FDA Approved: PAROXETINE — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Paroxetine by ANI Pharmaceuticals, Inc., indicating approval of a generic product under ANDA 215…
-
FDA approval · 2024-01-16FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Par Health USA, LLC)
FDA approved a supplemental application for a combined olanzapine and fluoxetine product, submitted by Par Health USA, LLC (brand name Symby…
-
FDA approval · 2024-01-16FDA Approved: DOXEPIN — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for the generic doxepin from Actavis Pharma, Inc., adding regulatory authorization for this prod…
-
FDA approval · 2024-01-11FDA Approved: VILAZODONE HYDROCHLORIDE — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for vilazodone hydrochloride submitted by Accord Healthcare Inc., allowing a generic version of the …